Value Added Medicines training for business development professionals

    Value Added Medicines / Scientific, Regulatory and IP Analysis

    New dates TBA, live online training

    Summary

    This unique training is focusing on highly evolving areas of Value Added Medicines business development. The participants will explore the scientific, regulatory, intellectual property and clinical challenges of innovative generic portfolio design.

    Learning Objectives

    • The concept of value in the health care environment
    • Analyze the market before embarking on an added value strategy
    • Create viable business models in different markets
    • Is repositioning a high-risk strategy – when could it be suitable for your company?
    • How to differentiate a generic product
    • Select the right route to drug approval
    • What type of products to stay away from because of clinical barriers
    • An in-depth scientific discussion of different mechanisms that could lead to an added value product
    • Case studies of Formulation patents – successes and failures
    • Consequences of market switch from Brand to INN generics

    Key Topics

    • Innovative Generic Business Development
    • A concept of value in health care environment
    • Market Access for Value Added Medicines
    • Drug Repositioning / Repurposing
    • Scientific and Technological solutions for Value Added Medicines
    • Clinical aspects
    • IP and data exclusivity
    • Formulation patents: successes and failures

    Who should attend?

    Product portfolio planners, Business development, C-level executives, Heads of R&D, Regulatory affairs, Market access, Mergers and Acquisitions managers, Intellectual property, Pricing & reimbursement

    Past participants

    • Head of Business Excellence, Zentiva Pharma
    • Head of R&D Project Management, G.L. Pharma
    • Head of Clinical Development, Lamda Laboratories
    • Business Development Manager, Morningside Healthcare Limited
    • Chief Business Development Officer, Sterling
    • Portfolio Manager, Sun Pharmaceuticals

    Our online training experience includes

    • Our client zone – a single source for all training materials as well as pre and post-training communication
    • Live interactive format via the Zoom platform
    • Direct interaction with the trainer
    • Q&As, case studies, polls
    • Revisit recorded sessions for 30 days
    • Digital and LinkedIn certificates

    Trainers

    Generapharm, CEO
    Dr. Ross has over 35 years experience in the Generics Industry, the last 15 being at corporate level. He has been intimately involved in strategic planning, pipeline management and related activities.
    Online Participation
    1 650  Price incl. VAT: 1 650 
    Equivalent of approx. 1 778 USD.
    The price calculation in USD is informative and might slightly differ from your bank exchange rate
    .

    Price per delegate including:

    Online participation

    Online workbook & materials

    Certificate

    PC, microphone, camera, stable internet connection and the Zoom application.

    Yes, we will make every effort to ensure best possible interaction. You will see the slides, interact with the trainer and fellow participants. Questions and group exercises will be facilitated through the online meeting platform.

    Yes, you can transfer the registration to a colleague at any time.

    Yes, you may transfer your registration to a different event up to one month before the scheduled dates, provided the training fee has been paid in full.

    pharma learning leader

    Lydia Makori

    l.makori@symmetric.events
    +421 222 200 543

    Training Details
    What participants said about this course

    "Very rich content with real world examples. Trianer is very strong in rich information/right content. Worth to take this training if your routes cross VAM development."
    Global Marketing Manager Pharma, DSM

    "A great journey through generic/vale added molecules and beyond. A must for people stepping into VAM world or already on a journey."
    Head of PM Specialties & Alliance Management, Stada Arzneimittel

    "Malcolm has been a wonderful trainer, he has huge experience in all fields and I feel we could be going deeper in any of the subjects for hours."
    R&D Pharmaceutical Scientist, Medichem

    "I appreciated the interactions with all participants."
    Research and Development Manager, E Pharma Trento

    "Very satisfied!"
    Global Marketing Director Pharma, DSM

    "Thank you Mr. Ross - it was great! Good training for knowing what's the emerging future like..."
    Business Development Manager, Solvias